|
MIVAC Development is located in the Biotech Center, Göteborg, Sweden. Address: Where we are |
News
Wednesday, May 16 2012
MIVAC Development has decided to no longer pursue the project for the development of a new vaccine against gastric ulcer and gastric cancer.
Read more >>>
Tuesday, December 20 2011
MIVAC Development creates a new company, Toleranzia AB, for the spin-out of the tolerance inducing Re-TolerogenTM platform.
Read more >>>
Thursday, November 24 2011
MIVAC development receives continued financial support from Innovationskontor Väst for the tolerance inducing Re-TolerogenTM platform.
Wednesday, August 17 2011
MIVAC Development creates a new company, Alzinova AB, for the spin-out of the AβCCTM-project.
Read more >>>